Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 9.6B | 10.3B | 17.2B | 12.7B |
Cost of revenue | 7.8B | 7.6B | 10.9B | 11.1B |
Gross profit | 1.8B | 2.7B | 6.3B | 1.6B |
Operating expense | ||||
Research & development | 279.4M | 567.2M | 1.3B | 247.6M |
Selling general and admin | 1.3B | 1.3B | 1.6B | 1.7B |
Other operating expenses | 592.1M | 57.1M | -4.0M | -85.4M |
Operating income | -2.2B | -1.3B | 1.8B | -1.7B |
Non operating interest income | ||||
Income | 31.9M | 45.4M | 148.8M | 40.9M |
Expense | 516.7M | 692.3M | 983.1M | 627.7M |
Other income expense | — | — | — | — |
Pretax income | -4.4B | -2.5B | 1.2B | 1.1B |
Tax provision | — | — | 49.4M | — |
Net income | -4.4B | -2.5B | 6.2B | 115.3M |
Basic EPS | -98 | -59 | — | 3 |
Diluted EPS | -98 | -59 | — | 3 |
Basic average shares | 44.8M | 43.5M | — | 42.8M |
Diluted average shares | 44.8M | 43.5M | — | 42.8M |
EBITDA | -2.3B | -674.5M | 877.9M | 2.0B |
Net income from continuing op. | -4.4B | -2.5B | 1.2B | 215.7M |
Minority interests | 36.4M | -69.4M | 59.5M | -4.4M |
Preferred stock dividends | — | — | — | — |